GB1552416A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1552416A
GB1552416A GB3347275A GB3347275A GB1552416A GB 1552416 A GB1552416 A GB 1552416A GB 3347275 A GB3347275 A GB 3347275A GB 3347275 A GB3347275 A GB 3347275A GB 1552416 A GB1552416 A GB 1552416A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3347275A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB3347275A priority Critical patent/GB1552416A/en
Priority to FR7624260A priority patent/FR2320731A1/fr
Publication of GB1552416A publication Critical patent/GB1552416A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
GB3347275A 1975-08-12 1975-08-12 Pharmaceutical compositions Expired GB1552416A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB3347275A GB1552416A (en) 1975-08-12 1975-08-12 Pharmaceutical compositions
FR7624260A FR2320731A1 (fr) 1975-08-12 1976-08-09 Composition pharmaceutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3347275A GB1552416A (en) 1975-08-12 1975-08-12 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1552416A true GB1552416A (en) 1979-09-12

Family

ID=10353410

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3347275A Expired GB1552416A (en) 1975-08-12 1975-08-12 Pharmaceutical compositions

Country Status (2)

Country Link
FR (1) FR2320731A1 (enExample)
GB (1) GB1552416A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
WO2004006917A1 (en) * 2002-07-16 2004-01-22 Ranbaxy Laboratories Limited Dispersible tablets for oral administration

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
DE2357503A1 (de) * 1973-11-17 1975-05-28 Cassella Farbwerke Mainkur Ag Verfahren zur herstellung von festen carbocromen-hydrochlorid enthaltenden praeparaten

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
WO2004006917A1 (en) * 2002-07-16 2004-01-22 Ranbaxy Laboratories Limited Dispersible tablets for oral administration

Also Published As

Publication number Publication date
FR2320731B1 (enExample) 1979-08-31
FR2320731A1 (fr) 1977-03-11

Similar Documents

Publication Publication Date Title
ZA7671B (en) Pharmaceutical composition
JPS5272829A (en) Pharmaceutical composition
JPS51150560A (en) Filmmforming compositions
JPS51150561A (en) Filmmforming compositions
ZA763917B (en) Pharmaceutical compositions and compounds
KE3219A (en) Pharmaceutical compositions
GB1538554A (en) Hydrocurable compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
GB1548675A (en) Odiurant compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
GB1549326A (en) Sunprotective compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
PT65171A (en) Match-head compositions
JPS5232924A (en) Soluvent compositions
ZA767215B (en) Pharmaceutical compositions
ZA761880B (en) New pharmaceutical compositions
GB1539031A (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
JPS5271552A (en) Compositions
ZA763806B (en) Pharmaceutical compositions
PH11642A (en) Benzocycloheptothiophenes and pharmaceutical compositions
GB1547998A (en) Photopolymersisable compositions
IE43955L (en) Pharmaceutical composition
IL51043A0 (en) Novel pharmaceutical compositions comprising ergot-type compounds

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee